5-9044535-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_003966.3(SEMA5A):c.2943C>T(p.Leu981=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0188 in 1,613,750 control chromosomes in the GnomAD database, including 398 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.014 ( 25 hom., cov: 32)
Exomes 𝑓: 0.019 ( 373 hom. )
Consequence
SEMA5A
NM_003966.3 synonymous
NM_003966.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.372
Genes affected
SEMA5A (HGNC:10736): (semaphorin 5A) This gene belongs to the semaphorin gene family that encodes membrane proteins containing a semaphorin domain and several thrombospondin type-1 repeats. Members of this family are involved in axonal guidance during neural development. This gene has been implicated as an autism susceptibility gene.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 5-9044535-G-A is Benign according to our data. Variant chr5-9044535-G-A is described in ClinVar as [Benign]. Clinvar id is 3059430.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.372 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0143 (2183/152216) while in subpopulation NFE AF= 0.0207 (1405/68012). AF 95% confidence interval is 0.0198. There are 25 homozygotes in gnomad4. There are 977 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 25 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEMA5A | NM_003966.3 | c.2943C>T | p.Leu981= | synonymous_variant | 22/23 | ENST00000382496.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEMA5A | ENST00000382496.10 | c.2943C>T | p.Leu981= | synonymous_variant | 22/23 | 1 | NM_003966.3 | P1 | |
ENST00000506519.1 | n.669+1258G>A | intron_variant, non_coding_transcript_variant | 3 | ||||||
SEMA5A | ENST00000652226.1 | c.2943C>T | p.Leu981= | synonymous_variant | 24/25 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0144 AC: 2186AN: 152098Hom.: 25 Cov.: 32
GnomAD3 genomes
AF:
AC:
2186
AN:
152098
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0117 AC: 2929AN: 251350Hom.: 27 AF XY: 0.0117 AC XY: 1596AN XY: 135868
GnomAD3 exomes
AF:
AC:
2929
AN:
251350
Hom.:
AF XY:
AC XY:
1596
AN XY:
135868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0192 AC: 28115AN: 1461534Hom.: 373 Cov.: 32 AF XY: 0.0187 AC XY: 13564AN XY: 727100
GnomAD4 exome
AF:
AC:
28115
AN:
1461534
Hom.:
Cov.:
32
AF XY:
AC XY:
13564
AN XY:
727100
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0143 AC: 2183AN: 152216Hom.: 25 Cov.: 32 AF XY: 0.0131 AC XY: 977AN XY: 74418
GnomAD4 genome
AF:
AC:
2183
AN:
152216
Hom.:
Cov.:
32
AF XY:
AC XY:
977
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SEMA5A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at